Vanita Noronha

Research interests

Publications

• Current Treatment Strategies and Risk Stratification for Oral Carcinoma

  American Society of Clinical Oncology Educational Book · 2023 · 10.1200/edbk_389810

• Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update

  Journal of Clinical Oncology · 2023 · https://doi.org/10.1200/jco.23.00933

• Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation

  Journal of Clinical Oncology · 2023 · 10.1200/jco.22.00980

• Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

  Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.22.01015

• Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer

  Journal of Clinical Oncology · 2021 · 10.1200/jco.21.00179

• Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.03282

• Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial

  The Lancet Global Health · 2020 · 10.1016/s2214-109x(20)30275-8

• Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung Cancer

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01154

• A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

  Cancer · 2019 · 10.1002/cncr.32179

• Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

  Frontiers in Oncology · 2019 · 10.3389/fonc.2019.00086

• Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

  Cancer Cell · 2018 · 10.1016/j.ccell.2018.09.010

• Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data

  The Oncologist · 2017 · https://doi.org/10.1634/theoncologist.2017-0015

• Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.74.9457

• Lung cancer in the Indian subcontinent

  South Asian Journal of Cancer · 2016 · 10.4103/2278-330x.187571

• A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck

  Oral Oncology · 2015 · 10.1016/j.oraloncology.2014.12.002

• Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers

  Oral Oncology · 2014 · 10.1016/j.oraloncology.2014.07.015

• Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity

  PLoS ONE · 2013 · 10.1371/journal.pone.0076164

• Crizotinib: A comprehensive review

  South Asian Journal of Cancer · 2013 · 10.4103/2278-330x.110506

• EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy

  PLoS ONE · 2013 · 10.1371/journal.pone.0061561

• Epidemiology of lung cancer in India: Focus on the differences between non-smokers and smokers: A single-centre experience

  Indian Journal of Cancer · 2012 · 10.4103/0019-509x.98925

• Blood stream infections in cancer patients: A single center experience of isolates and sensitivity pattern

  Indian Journal of Cancer · 2010 · 10.4103/0019-509x.63019

• Primary non-Hodgkin's lymphoma of the liver

  Critical Reviews in Oncology/Hematology · 2004 · 10.1016/j.critrevonc.2004.10.010

Current projects

No projects listed.